Fundraising FoxTrevarx Biomedical
Philadelphia, US · Founded 2016 · Delaware corporation
Find your way into Trevarx Biomedical
Each arrow is one introduction. Sign up to fill in the first one.
443 people can intro you to Jean
Ask Paul Durrant to introduce you to Jean Cho
You →Paul · together at Drexel Burnham Lambert →Jean
Sign up to find every way you can get introduced to Trevarx Biomedical
- Your email: who you already know at Trevarx Biomedical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Trevarx Biomedical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
JC
Jean ChoExecutiveJean Cho is co-founder and Executive Officer at Trevarx Biomedical, a biotech company developing alpha radiopharmaceutical therapies for cancer treatment. She previously held roles in finance and technology companies and has experience in non-profit leadership.
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 3 rounds · 2019–2025
▶$350KraisedAug 2025 · 6 investors · BiotechnologyRule 506(b)
▶$350KraisedAug 2025 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean ChoExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $350K
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedSep 2022 · 10 investors · BiotechnologyRule 506(b)
▶$500KraisedSep 2022 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean ChoExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$650KraisedAug 2019 · 11 investors · OtherRule 506(b)
▶$650KraisedAug 2019 · 11 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jean ChoExecutive Officer, Director
- Offering amount
- $850K
- Amount sold
- $650K
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Trevarx Biomedical raised?
- Trevarx Biomedical has disclosed $1.5M raised across 3 rounds.
- Where is Trevarx Biomedical headquartered?
- Trevarx Biomedical is headquartered in Philadelphia, US.